Background illustration for clinical trials search

Paid Clinical Trials Naperville

Discover 2,409 paid clinical trials in Naperville, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Featured

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

for
Non-Small Cell Lung Cancer, c-MET
Location: Niles IL, Chicago IL, Springfield IL, Perrysburg OH,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06568939

Phase 2, Recruiting
Featured

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

for
Advanced Prostate Cancer, Metastatic Prostate Cancer
Location: Chicago IL, Nashville TX, Toronto, New Haven CT,
Sponsor: Genentech, Inc.

Sex: Male

Age: 18+

Code: NCT05800665

Phase 1, Recruiting
Featured

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Chicago IL, Peoria IL, Urbana IL, Fort Wayne IN,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06890338

Phase 2, Recruiting
Featured

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for
Crohn's Disease
Location: Chicago IL, Peoria IL, Springfield IL, Indianapolis IN,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase 2, Recruiting
Featured

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

for
Ovarian Cancer
Location: Chicago IL, Omaha NE, Fairfax VA, Denver CO,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07278336

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Chicago IL, Zion IL, Peoria IL, Madison WI,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07365241

Phase 3, Recruiting
Featured

A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma

for
Metastatic Pancreatic Ductal Adenocarcinoma, PDAC
Location: Chicago IL, Zion IL, Grand Rapids MI, St Louis MO,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07490301

Phase 2, Phase 3, Recruiting
Featured

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Chicago IL, Grand Rapids MI, Newnan GA, Denver CO,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07409246

Phase 1, Recruiting
Featured

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

for
Non-Small Cell Lung Cancer
Location: Chicago IL, Grand Rapids MI, St Louis MO, Cincinnati OH,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06236438

Phase 2, Phase 3, Recruiting
Featured

A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors

for
Advanced Squamous Tumors
Location: Chicago IL, Grand Rapids MI, Toronto, Huntersville NC,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07241039

Phase 1, Recruiting
Featured

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

for
Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma,
Location: Chicago IL, Grand Rapids MI, St Louis MO, Cleveland OH,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06084481

Phase 1, Recruiting
Featured

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

for
Colorectal Cancer
Location: Chicago IL, Cincinnati OH, Kansas City MO,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07525206

Phase 3, Recruiting
Featured

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

for
Ulcerative Colitis
Location: Chicago IL, Monroe NC, Fresh Meadows NY, Montreal,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06979336

Phase 2, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

for
Colorectal Cancer
Location: Chicago IL, Ann Arbor MI, Rochester MN, Minneapolis MN,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07023289

Phase 2, Recruiting
Featured

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

for
Ulcerative Colitis
Location: Chicago IL, Cleveland OH, London, Pittsburgh PA,
Sponsor: AbbVie

Sex: All

Age: 2 - 17

Code: NCT07071519

Phase 3, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

for
Hepatocellular Cancer, Squamous-Cell Non-Small Cell Lung Cancer
Location: Chicago IL, St Louis MO, Nashville TN, Philadelphia PA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06858813

Phase 1, Recruiting
Featured

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

for
Obesity, Overweight
Location: Chicago IL, City of Saint Peters MO, Cincinnati OH,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07752979

Phase 2, Recruiting
Featured

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Chicago IL, Wyoming MI, St Louis MO, Beavercreek OH,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819891

Phase 3, Recruiting
Featured

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

for
Alzheimers Disease
Location: Chicago IL, St Louis MO, Farmington Hills MI,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07177352

Phase 3, Recruiting
Featured

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

for
Muscular Atrophy, Spinal
Location: Chicago IL, Grand Rapids MI, Little Rock AR, Atlanta GA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 0 - 2

Code: NCT05861986

Recruiting